Project Statistics: Evaluación de TDF como potencial fármaco antitumoral.
Geo Map
Region
#
NA - North America
361
EU - Europe
71
AS - Asia, other
48
SA - South America
2
AF - Africa
1
OC - Oceania
1
Unknown
34
Total
518
Country
#
US - United States of America
358
SG - Singapore
27
ES - Spain
20
DE - Germany
13
CN - China
11
SE - Sweden
10
VN - Vietnam
8
RU - Russian Federation
7
GB - United Kingdom
4
IE - Ireland
4
other - Other Country
56
Total
518
City
#
Las Palmas de Gran Canaria
18
Singapore
11
Santa Clara
6
Beijing
5
Bucharest
4
Dallas
4
Dublin
4
Fort Worth
4
Chandler
3
Braunschweig
2
other
457
Total
518
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2021
0 0
0 0 14 0
0 8 0 0
2 8
32
2022
4 0
0 0 0 0
0 0 0 5
1 3
13
2023
0 1
0 3 1 1
1 12 257 0
1 0
277
2024
12 1
3 7 3 4
5 23 33 8
4 2
105
2025
7 7
0 0 1 8
6 0 15 5
1 4
54
2026
7 2
5 5 12 0
0 0 0 0
0 0
31
Ever
518
Geo Map
| Region | # |
|---|---|
| NA - North America | 361 |
| EU - Europe | 71 |
| AS - Asia, other | 48 |
| SA - South America | 2 |
| AF - Africa | 1 |
| OC - Oceania | 1 |
| Unknown | 34 |
| Total | 518 |
| Country | # |
|---|---|
| US - United States of America | 358 |
| SG - Singapore | 27 |
| ES - Spain | 20 |
| DE - Germany | 13 |
| CN - China | 11 |
| SE - Sweden | 10 |
| VN - Vietnam | 8 |
| RU - Russian Federation | 7 |
| GB - United Kingdom | 4 |
| IE - Ireland | 4 |
| other - Other Country | 56 |
| Total | 518 |
| City | # |
|---|---|
| Las Palmas de Gran Canaria | 18 |
| Singapore | 11 |
| Santa Clara | 6 |
| Beijing | 5 |
| Bucharest | 4 |
| Dallas | 4 |
| Dublin | 4 |
| Fort Worth | 4 |
| Chandler | 3 |
| Braunschweig | 2 |
| other | 457 |
| Total | 518 |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 0 | 0 | 0 | 0 | 14 | 0 | 0 | 8 | 0 | 0 | 2 | 8 | 32 |
| 2022 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 1 | 3 | 13 |
| 2023 | 0 | 1 | 0 | 3 | 1 | 1 | 1 | 12 | 257 | 0 | 1 | 0 | 277 |
| 2024 | 12 | 1 | 3 | 7 | 3 | 4 | 5 | 23 | 33 | 8 | 4 | 2 | 105 |
| 2025 | 7 | 7 | 0 | 0 | 1 | 8 | 6 | 0 | 15 | 5 | 1 | 4 | 54 |
| 2026 | 7 | 2 | 5 | 5 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31 |
| Ever | 518 | ||||||||||||